New study aims to find best drug to stop eye weakness from spreading

NCT ID NCT04182984

First seen Jan 31, 2026 · Last updated Jun 05, 2026 · Updated 23 times

Summary

This study looks at different immunosuppressant drugs in 200 adults with ocular myasthenia gravis (OMG), a condition causing eye muscle weakness. The goal is to see which treatment best controls symptoms and prevents the disease from spreading to other muscles. Researchers will track side effects and measure improvements in muscle function and daily activities.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OCULAR MYASTHENIA GRAVIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tangdu Hospotal

    RECRUITING

    Xi'an, Shaanxi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.